1Drop Diagnostics
PrivateLast Round
Series A
Oct 31, 2018
Total Funding Raised
$4.67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
1Drop Diagnostics operates in Healthcare & Life Sciences and is based in Neuchâtel. Its latest recorded funding round was a Series A round in October 2018.
1Drop Diagnostics is a life science company that develops and commercializes a portable medical diagnostic platform for point-of-care testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1Drop Diagnostics Comparables
Compare 1Drop Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omini | 83% | |
| Chronus Health, Inc. | 82% | |
| Vital Bio | 82% |
For institutional investors. Book with your work email.
1Drop Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 31, 2018 | ||||
| Grant | Apr 25, 2017 | ||||
| Accelerator | Feb 25, 2016 | ||||
| Grant | Jun 26, 2015 | ||||
| Grant | Oct 20, 2014 | ||||
Accelerator | May 22, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
1Drop Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blackbox | Accelerator |
| ventureLAB | Series A |
| W.A. de Vigier Foundation | Grant |
| Banque Cantonale Neuchâteloise | Grant |
| MassChallenge Israel | Accelerator |
| Eidgenössische Stiftung zur Förderung schweizerischer Volkswirtschaft durch wissenschaftliche Forschung | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 53% MoM, from 2.6K to 4K.
- Oct 31, 2018
$4.25M round led by Christian Wildmoser.
For institutional investors. Book with your work email.
1Drop Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 1Drop Diagnostics's valuation, stock price, and market status.
Is 1Drop Diagnostics a public or private company?
1Drop Diagnostics is a private company.
What is the current stock price of 1Drop Diagnostics?
1Drop Diagnostics is a private company, so its shares have no public market price. Caplight tracks 1Drop Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 1Drop Diagnostics worth (valuation)?
Valuation information for 1Drop Diagnostics is not publicly available.
Can I buy 1Drop Diagnostics stock?
1Drop Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 1Drop Diagnostics's last funding round?
1Drop Diagnostics's most recent funding round was Series A on October 31, 2018.
Who are the main investors in 1Drop Diagnostics?
Key investors in 1Drop Diagnostics include Blackbox, ventureLAB, W.A. de Vigier Foundation, Banque Cantonale Neuchâteloise, MassChallenge Israel.
Will 1Drop Diagnostics IPO soon?
No public IPO plans have been announced for 1Drop Diagnostics.
How can I track 1Drop Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in 1Drop Diagnostics's shares on secondary markets.